Anesthetic Efficacy of Liposomal Prilocaine in Maxillary Infiltration Anesthesia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01073371 |
Recruitment Status :
Completed
First Posted : February 23, 2010
Last Update Posted : February 23, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Dental Anesthesia Efficacy | Drug: Prilocaine | Phase 1 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 32 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Supportive Care |
Official Title: | Local Anesthetics New Formulations: From Development to Clinical Tests |
Study Start Date : | July 2008 |
Actual Primary Completion Date : | August 2009 |
Actual Study Completion Date : | November 2009 |

Arm | Intervention/treatment |
---|---|
Active Comparator: liposome-encapsulated 3% prilocaine |
Drug: Prilocaine
1.8mL infiltration of liposome-encapsulated 3% prilocaine, 3% plain prilocaine or 3% prilocaine with 0,03IU/mL felypressin in the buccal sulcus of the maxillary right canine
Other Name: Citocaína® |
Active Comparator: 3% plain prilocaine |
Drug: Prilocaine
1.8mL infiltration of liposome-encapsulated 3% prilocaine, 3% plain prilocaine or 3% prilocaine with 0,03IU/mL felypressin in the buccal sulcus of the maxillary right canine
Other Name: Citocaína® |
Active Comparator: 3% prilocaine with 0,03IU/mL felypressin |
Drug: Prilocaine
1.8mL infiltration of liposome-encapsulated 3% prilocaine, 3% plain prilocaine or 3% prilocaine with 0,03IU/mL felypressin in the buccal sulcus of the maxillary right canine
Other Name: Citocaína® |
- Anesthesia success, onset and duration of pulpal and gingival anesthesia. [ Time Frame: 10 minutes ]
- Injection pain - Visual Analogue Scale [ Time Frame: 1 minute after the injections ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 35 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- good health
- no history of allergy to the components of the local anesthetic formulations tested
- maxillary canine, lateral incisor, and first premolar responsible to electric stimulation
Exclusion Criteria:
- intake of any medication that would alter pain perception
- history of trauma or sensitivity, caries, restorations, periodontal disease and endodontic treatment in the maxillary canine, lateral incisor, and first premolar
- systemic disease

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01073371
Brazil | |
Piracicaba Dental School | |
Piracicaba, SP, Brazil, 13414903 |
Study Director: | Eneida de Paula, PhD | University of Campinas, Brazil |
Responsible Party: | Patrícia Maria Wiziack Zago, University of Campinas, Brazil |
ClinicalTrials.gov Identifier: | NCT01073371 |
Other Study ID Numbers: |
131843/2008-7 |
First Posted: | February 23, 2010 Key Record Dates |
Last Update Posted: | February 23, 2010 |
Last Verified: | June 2008 |
Liposome Prilocaine Dental anesthesia |
Prilocaine Anesthetics, Local Anesthetics Central Nervous System Depressants |
Physiological Effects of Drugs Sensory System Agents Peripheral Nervous System Agents |